Role of CDK4/6 inhibitors in patients with hormone receptor (HR)-positive, human epidermal receptor-2 negative (HER-2) metastatic breast cancer study protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.
Qiancheng HuWenli KangQingfeng WangTing LuoPublished in: BMJ open (2022)
CRD42021266597.